{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:14Z","timestamp":1786118654242,"version":"build-2736575974"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/bor.0b013e32802106b9","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T20:08:32Z","timestamp":1170446912000},"page":"122-127","source":"Crossref","is-referenced-by-count":31,"title":["Therapeutic advances in gout"],"prefix":"10.1097","volume":"19","author":[{"given":"Eliseo","family":"Pascual","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Sivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7326\/0003-4819-86-2-230","article-title":"The pathogenesis of podagra","volume":"86","author":"Simkin","year":"1977","journal-title":"Ann Intern Med"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/ard.57.4.255","article-title":"Orderly arrayed deposit of urate crystals in gout suggest epitaxial formation","volume":"57","author":"Pascual","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/0003-4819-54-3-452","article-title":"Identification of urate crystals in gouty synovial fluid","volume":"54","author":"McCarty","year":"1961","journal-title":"Ann Intern Med"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/0003-4819-131-10-199911160-00007","article-title":"Synovial fluid analysis for diagnosis of intercritical gout","volume":"131","author":"Pascual","year":"1999","journal-title":"Ann Intern Med"},{"key":"R5-8-20210128","first-page":"577","article-title":"Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?","volume":"28","author":"Li-Yu","year":"2001","journal-title":"J Rheumatol"},{"key":"R7-8-20210128","first-page":"1383","article-title":"Withdrawal of longterm antihyperuricemic therapy in tophaceous gout","volume":"20","author":"van Lieshout-Zuidema","year":"1993","journal-title":"J Rheumatol"},{"key":"R8-8-20210128","first-page":"1246","article-title":"Intermittent control of hyperuricemia in the treatment of gout","volume":"16","author":"Bull","year":"1989","journal-title":"J Rheumatol"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout \u2013 Part II Management: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"25","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/art.20102","article-title":"Quality of care indicators for gout management","volume":"50","author":"Mikuls","year":"2004","journal-title":"Artritis Rheum"},{"key":"R11-8-20210128","first-page":"2453","article-title":"Outcome measures for acute and chronic gout","volume":"32","author":"Schumacher","year":"2005","journal-title":"J Rheumatol"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout - Part I Diagnosis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.2004.027268","article-title":"Analysis for crystals in synovial fluid: training of the analysts results in high consistency","volume":"64","author":"Lumbreras","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R15-8-20210128","first-page":"1575","article-title":"Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims","volume":"31","author":"Riedel","year":"2004","journal-title":"J Rheumatol"},{"key":"R16-8-20210128","first-page":"562","article-title":"Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internet-accessible error reporting system","volume":"33","author":"Mikuls","year":"2006","journal-title":"J Rheumatol"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4065\/81.7.925","article-title":"Gout medication treatment patterns and adherence to standards of care from a managed care perspective","volume":"81","author":"Sarawate","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R18-8-20210128","first-page":"104","article-title":"Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study","volume":"33","author":"Neogi","year":"2006","journal-title":"J Rheumatol"},{"key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0002-9343(51)90028-9","article-title":"Mobilization of gouty tophi by protracted use of uricosuric agents","volume":"11","author":"Y\u00fc","year":"1951","journal-title":"Am J Med"},{"key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R21-8-20210128","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Eng J Med"},{"key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricemia. A pathogenic approach to the treatment of primary chronic gout","volume":"57","author":"P\u00e9rez-Ruiz","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"R23-8-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/rheumatology\/26.6.445","article-title":"Plasma oxipurinol concentrations during allopurinol therapy","volume":"26","author":"Emmerson","year":"1987","journal-title":"Br J Rheumatol"},{"key":"R24-8-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.rhu.0000164822.98163.22","article-title":"Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol-related toxicity","volume":"11","author":"Perez-Ruiz","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"R25-8-20210128","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1345\/aph.1G589","article-title":"Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients","volume":"40","author":"Raebel","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R26-8-20210128","first-page":"1646","article-title":"Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout","volume":"33","author":"Dalbeth","year":"2006","journal-title":"J Rheumatol"},{"key":"R27-8-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","article-title":"Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level","volume":"47","author":"Siu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R28-8-20210128","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000045783","article-title":"Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts","volume":"86","author":"Perez-Ruiz","year":"2000","journal-title":"Nephron"},{"key":"R29-8-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/bmj.331.7517.623","article-title":"Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia","volume":"331","author":"Gutierrez-Macias","year":"2005","journal-title":"BMJ"},{"key":"R30-8-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(92)90236-5","article-title":"Desensitization to allopurinol in patients with gout and cutaneous reactions","volume":"93","author":"Fam","year":"1992","journal-title":"Am J Med"},{"key":"R31-8-20210128","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/art.10792","article-title":"Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R32-8-20210128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.2005.049023","article-title":"Gout, diuretics and the kidney","volume":"65","author":"Pascual","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R33-8-20210128","first-page":"U1528","article-title":"Benzbromarone therapy in the management of refractory gout","volume":"118","author":"Kumar","year":"2005","journal-title":"N Z Med J"},{"key":"R34-8-20210128","first-page":"651","article-title":"Benzbromarone withdrawn from the European market: another case of \u201cabsence of evidence is evidence of absence\u201d?","volume":"22","author":"Jansen","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R35-8-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","article-title":"Treatment of chronic gout in patients with renal function impairment. An open, randomized, actively controlled study","volume":"5","author":"P\u00e9rez-Ruiz","year":"1999","journal-title":"J Clin Rheumatol"},{"key":"R36-8-20210128","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/ndt\/9.5.548","article-title":"Excellent uricosuric efficacy of benzbromarone in cyclosporin-A treated renal transplant patients: a prospective study","volume":"9","author":"Z\u00fcrcher","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"R37-8-20210128","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000188609","article-title":"Impairment of tubular secretion of urate in renal transplant patients on cyclosporine","volume":"70","author":"Marc\u00e9n","year":"1995","journal-title":"Nephron"},{"key":"R38-8-20210128","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R39-8-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000028589.66335.AA","article-title":"Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity","volume":"40","author":"Watanabe","year":"2002","journal-title":"Hypertension"},{"key":"R40-8-20210128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/oxfordjournals.molbev.a004123","article-title":"Loss of urate oxidase activity in hominoids and its evolutionary implications","volume":"19","author":"Oda","year":"2002","journal-title":"Mol Biol Evol"},{"key":"R41-8-20210128","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman","year":"2001","journal-title":"Blood"},{"key":"R42-8-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ndt\/gfh629","article-title":"Urate oxidase (rasburicase) for treatment of severe tophaceous gout","volume":"20","author":"Vogt","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R43-8-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ncprheum0214","article-title":"Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol","volume":"2","author":"Richette","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R44-8-20210128","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10067-005-0043-y","article-title":"Rasburicase treatment in severe tophaceous gout: a novel therapeutic option","volume":"25","author":"Moolenburgh","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R45-8-20210128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/art.1780340203","article-title":"Persistence of monosodium urate crystals, and low grade inflammation, in the synovial fluid of untreated gout","volume":"34","author":"Pascual","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R46-8-20210128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/rheumatology\/34.8.724","article-title":"A quantitative study of the phagocytosis of urate crystals in the synovial fluid of asymptomatic joints of patients with gout","volume":"34","author":"Pascual","year":"1995","journal-title":"Br J Rheumatol"},{"key":"R47-8-20210128","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/rheumatology\/kel071","article-title":"Effectiveness of interventions for the treatment of acute and prevention of recurrent gout \u2013 a systematic review","volume":"45","author":"Sutaria","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R48-8-20210128","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.20007","article-title":"Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial","volume":"50","author":"Rubin","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R49-8-20210128","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/jama.296.13.jrv60015","article-title":"Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: Meta-analysis of randomized trials","volume":"296","author":"Zhang","year":"2006","journal-title":"JAMA"},{"key":"R50-8-20210128","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","article-title":"Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison","volume":"368","author":"Cannon","year":"2006","journal-title":"Lancet"},{"key":"R51-8-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-0172(90)90070-V","article-title":"Systemic steroid therapy for acute gout: A clinical trial and review of the literature","volume":"19","author":"Groff","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"R52-8-20210128","first-page":"696","article-title":"ACTH revisited: Effective treatment for acute crystal induced synovitis in patients with multiple medical problems","volume":"21","author":"Ritter","year":"1994","journal-title":"J Rheumatol"},{"key":"R53-8-20210128","first-page":"S49","article-title":"Treatment of gouty attacks with a small dose of intraarticular triamcinolone acetonide","volume":"40","author":"Fern\u00e1ndez","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R54-8-20210128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/rheumatology\/34.5.481","article-title":"Management of gout in patients with renal insufficiency and a gastrointestinal bleed \u2013 an answer to Dr Dunne's letter","volume":"34","author":"Pascual","year":"1995","journal-title":"Br J Rheumatol"},{"key":"R55-8-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work?. The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust NZ J Med"},{"key":"R56-8-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/emj.2002.004036","article-title":"Troponin for prediction of cardiovascular collapse in acute colchicine overdose","volume":"22","author":"van Heyningen","year":"2005","journal-title":"Emerg Med J"},{"key":"R57-8-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/431592","article-title":"Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study","volume":"41","author":"Hung","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R58-8-20210128","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1592\/phco.24.17.1784.52334","article-title":"Colchicine myotoxicity: case reports and literature review","volume":"24","author":"Wilbur","year":"2004","journal-title":"Pharmacotherapy"},{"key":"R59-8-20210128","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1345\/aph.1E593","article-title":"Acute myopathy in a patient with concomitant use of pravastatin and colchicine","volume":"39","author":"Alayli","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R60-8-20210128","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/ard.2003.015743","article-title":"Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with antitumour necrosis factor alpha as a new therapeutic option","volume":"63","author":"Tausche","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R61-8-20210128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/art.1780340203","article-title":"Persistence of monosodium urate crystals, and low grade inflammation, in the synovial fluid of untreated gout","volume":"34","author":"Pascual","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R62-8-20210128","first-page":"600","article-title":"Treatment with colchicine decreases the white cell counts in the synovial fluid of asymptomatic knees which contain monosodium urate crystals","volume":"19","author":"Pascual","year":"1992","journal-title":"J Rheumatol"},{"key":"R63-8-20210128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0049-0172(82)90065-8","article-title":"The efficacy of colchicine prophylaxis in articular gout \u2013 a reappraisal after 20 years","volume":"12","author":"Yu","year":"1982","journal-title":"Semin Arthritis Rheum"},{"key":"R64-8-20210128","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"R65-8-20210128","first-page":"595","article-title":"Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels","volume":"19","author":"Beutler","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"R66-8-20210128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","article-title":"Serum urate levels and gout flares: analysis from managed care data","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"R67-8-20210128","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.1991.03470210076036","article-title":"Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration","volume":"266","author":"Facchini","year":"1991","journal-title":"JAMA"},{"key":"R68-8-20210128","first-page":"1188","article-title":"Dietary alterations in plasma very low density lypoprotein levels modify renal excretion of urates in hyperuricemic-hypertriglyceridemic patients","volume":"82","author":"Tirahones","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R69-8-20210128","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study","volume":"165","author":"Choi","year":"2005","journal-title":"Arch Intern Med"},{"key":"R70-8-20210128","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R72-8-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.bor.0000209434.82096.1f","article-title":"Recent developments in diet and gout","volume":"18","author":"Lee","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"R73-8-20210128","first-page":"341","article-title":"Gout: epidemiology and lifestyle choices","volume":"17","author":"Choi","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"R74-8-20210128","first-page":"773","article-title":"Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet","volume":"32","author":"Fam","year":"2005","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"R75-8-20210128","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1907","article-title":"Epidemiology, risk factors, and lifestyle modifications for gout","volume":"8","author":"Saag","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"R76-8-20210128","first-page":"1341","article-title":"Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study","volume":"33","author":"Hunter","year":"2006","journal-title":"J Rheumatol"},{"key":"R77-8-20210128","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.2005.040360","article-title":"Gout, not induced by diuretics? A case\u2013control study from primary care","volume":"65","author":"Janssens","year":"2006","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e32802106b9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:23:02Z","timestamp":1786033382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-200703000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e32802106b9","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}